To validate albumin Cys34 as a clinical biomarker for myonecrosis in DMD, our group is investigating the correlation between thiol oxidation of albumin Cys34 in plasma and protein thiol oxidation in the muscle tissue of mouse models. Here, ALB is linked to gas gangrene.